Delivering in vitro diagnostics expertise for over 100 years

Medix Biochemica, established in 1985, has become a global and market-leading supplier to the IVD industry. Our innovative approach delivers commercially successful antibodies with pioneering antibody technology based on in vitro manufacturing under ISO 13485 certified operations. Our wide product portfolio of bioreagents is well-known under the brand names MedixMAB™ Antibodies and MedixAntigens™. MedixMAB antibodies are in use in billions of diagnostic tests all around the world to ensure accurate diagnostic results.

Through our Actim® solution we are leaders in rapid testing of pregnancy complications. In addition to women’s health, we partner with leading IVD companies to make Actim® a reliable option for healthcare professionals who require accurate point-of care results within minutes for their patients with infectious diseases and gastrointestinal problems.

The 2019 acquisition of Lee Biosolutions strenghtened our position as a global leader, and extended our offering to include high quality antigens, proteins and enzymes for a wide range of life science research and diagnostic applications through novel extraction methodologies and classical chromatography techniques. Lee Biosolutions has a long, successful history serving the IVD and research markets since 1975.

In 2020 Medix Biochemica acquired EastCost Bio, enabling us to serve IVD companies with broader offering of high-quality antibodies, especially for drugs of abuse and infections tests. Formed in 1995, EastCoast Bio has become well known for quick service, consistently dependable products, and knowledgeable support.

Together, we bring 105 years of diagnostics expertise to our customers all over the world. Our evolution and our focus on quality underpin our ambition to be the trusted partner and #1 supplier to the IVD companies.

 

Medix Biochemica Group infographic